Results 151 to 160 of about 1,132,527 (387)

Relationship between antimicrobial proteins and airway inflammation and infection in cystic fibrosis [PDF]

, 2009
Scott D. Sagel, Marci K. Sontag, Frank J. Accurso   +2 more
openalex   +1 more source

Cystic fibrosis [PDF]

Clinical Medicine, 2007
Jane C, Davies, Eric W F W, Alton, Andrew, Bush   +2 more
  +9 more sources

Cystic fibrosis [PDF]

Nature, 1980
G L, Adams, P, Hilger, W J, Warwick
  +7 more sources

Exploring the utilisation and effectiveness of implementation science strategies by cystic fibrosis registries for healthcare improvement: a systematic review

European Respiratory Review
Background Cystic fibrosis (CF) registries capture important information in high-burden health domains to support improvement in health outcomes, although a number of unanswered questions persist, as follows.
Rob G. Stirling, Bhumika Sood, Macken J.L. Stirling, Tom Kotsimbos, Dominic T. Keating, Catherine E. Rang, James M. Trauer, Alan C. Young, Christiaan Yu, Julianna Bailey, Peter Wark, Angela Melder, Paul Dawkins   +12 more
doaj   +1 more source

Eradication therapy forBurkholderia cepaciacomplex in people with cystic fibrosis [PDF]

, 2019
Kate Regan, Jayesh Bhatt
openalex   +1 more source

CFTR modulators response of S737F and T465N CFTR variants on patient-derived rectal organoids

Orphanet Journal of Rare Diseases
Background Predictions based on patient-derived materials of CFTR modulators efficacy have been performed lately in patient-derived cells, extending FDA-approved drugs for CF patients harboring rare variants.
Karina Kleinfelder, Paola Melotti, Anca Manuela Hristodor, Cristina Fevola, Giovanni Taccetti, Vito Terlizzi, Claudio Sorio   +6 more
doaj   +1 more source

Lung clearance index short-term variability in cystic fibrosis: a pre-post pulmonary exacerbation study

Italian Journal of Pediatrics
Background Multiple Breath washout (MBW) represents an important tool to detect early a possible pulmonary exacerbation especially in Cystic Fibrosis (CF) disease.
Matteo De Marchis, Enza Montemitro, Alessandra Boni, Alessandra Federici, Daniele Di Giovanni, Luca Cristiani, Renato Cutrera, Alessandro G. Fiocchi   +7 more
doaj   +1 more source

The future of cystic fibrosis care: a global perspective.

The Lancet Respiratory Medicine, 2020
S. Bell, M. Mall, H. Gutierrez, M. Macek, S. Madge, J. Davies, P. Burgel, E. Tullis, C. Castaños, C. Castellani, C. Byrnes, F. Cathcart, S. H. Chotirmall, R. Cosgriff, I. Eichler, I. Fajac, C. Goss, P. Dřevínek, P. Farrell, A. Gravelle, T. Havermans, N. Mayer-Hamblett, N. Kashirskaya, E. Kerem, J. Mathew, E. McKone, L. Naehrlich, S. Nasr, G. Oates, C. O’Neill, Ulrike Pypops, K. Raraigh, S. Rowe, K. Southern, S. Sivam, A. Stephenson, M. Zampoli, F. Ratjen   +37 more
semanticscholar   +1 more source

Expert Perspective: Diagnosis and Treatment of Castleman Disease

Arthritis &Rheumatology, EarlyView.
Castleman disease (CD) is a major diagnostic challenge for rheumatologists. Unicentric CD (UCD) involves one enlarged lymph node region, whereas multicentric CD (MCD) involves multiple enlarged lymph node regions. Both UCD and MCD may exhibit a wide range of symptoms that overlap with other immune‐mediated conditions.
Luke Y. C. Chen, Lu Zhang, David C. Fajgenbaum   +2 more
wiley   +1 more source

Detection of cytokines in nasal lavage samples of patients with cystic fibrosis: comparison of two different cytokine detection assays

BMC Pulmonary Medicine
Background Cystic fibrosis (CF) is a genetic multisystem disorder. Inflammatory processes, which presumably begin early in infancy, play a crucial role in the progression of the disease. The detection of inflammatory biomarkers, especially in the airways,
Teresa Fuchs, Manuela Zlamy, Thomas Zöggeler, Dorothea Appelt, Katharina Niedermayr, Anja Siedl, Verena Gasser, Johannes Eder, Helmut Ellemunter   +8 more
doaj   +1 more source